The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...

UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was ...

A bill filed Thursday (Jan. 16) in the Arkansas Legislature would prohibit pharmacy benefit managers and insurance companies ...

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

The Arkansas Pharmacists Association is calling for public and legislative support for stronger regulation of Pharmacy ...

Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...

The Federal Trade Commission published a second interim staff report this week on the prescription drug middleman industry, which ...

HB1150 would ban the around 35 PBM-owned pharmacies in the state and prevent over 100 out-of-state PBM-owned pharmacies from ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...